M. Moriarty

2.9k citations

60 papers · 1.8k indexed · h-index 18

Impact in

Oncology top 5%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
Cancer Research top 10%

Papers in ⓘ

Oncology 19
- Pancreatic and Hepatic Oncology Research 6
Surgery 14
- Management of metastatic bone disease 7

Co-authors: David Gibbons (2 shared papers)John Hyland (2 shared papers)D. Fennelly (2 shared papers)Anne White (2 shared papers)Diarmuid P. O’Donoghue (1 shared paper)Darren Treanor (1 shared paper)Kieran Sheahan (1 shared paper)Hugh Mulcahy (2 shared papers)
Journals: British Journal of Cancer (6 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)British Journal of Radiology (3 papers)Radiotherapy and Oncology (2 papers)Histopathology (1 paper)
Partner nations: Ireland United States United Kingdom

In The Last Decade

M. Moriarty

58 papers receiving 1.7k citations

Peers

Countries citing papers authored by M. Moriarty

Since Specialization

Citations

This map shows the geographic impact of M. Moriarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Moriarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Moriarty more than expected).

Fields of papers citing papers by M. Moriarty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Moriarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Moriarty. The network helps show where M. Moriarty may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Moriarty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Moriarty Line = papers co-authored together M. Moriarty links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancer Histopathology ·Ronan Ryan, David Gibbons, John Hyland, Darren Treanor, Anne White, Hugh Mulcahy, Diarmuid P. O’Donoghue, M. Moriarty, D. Fennelly, Kieran Sheahan	2005	497
2	Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis Carcinogenesis ·Colin Clarke, Stephen F. Madden, Padraig Doolan, Sinéad Aherne, Helena Joyce, Lorraine O’Driscoll, William M. Gallagher, Bryan T. Hennessy, M. Moriarty, John Crown, Susan Kennedy, Martin Clynes	2013	294
3	Quality-of-Life Measurement in Advanced Cancer: Assessing the Individual Journal of Clinical Oncology ·Dympna Waldron, Ciaran A. O’Boyle, Michael Kearney, M. Moriarty, Desmond N. Carney	1999	156
4	A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant Chemoradiotherapy Annals of Surgical Oncology ·David Beddy, John Hyland, D. C. Winter, Lim C, Anne White, M. Moriarty, John Armstrong, D. Fennelly, David Gibbons, K. Sheahan	2008	116
5	2‐D difference gel electrophoresis of the lung squamous cell carcinoma *versus* normal sera demonstrates consistent alterations in the levels of ten specific proteins Electrophoresis ·Paul Dowling, Lorraine O’Driscoll, Paula Meleady, Michael Henry, Shunil Roy, Jo Ballot, M. Moriarty, John Crown, Martin Clynes	2007	63
6	Radiotherapy and the potential exploitation of bystander effects International Journal of Radiation OncologyBiologyPhysics ·Carmel Mothersill, M. Moriarty, Colin Seymour	2004	56
7	Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy Radiotherapy and Oncology ·P. Thirion, Ola Holmberg, Conor D. Collins, C. O'Shea, M. Moriarty, M. Pomeroy, Catriona O'Sullivan, Steve Buckney, John Armstrong	2004	49
8	A case-control study of head and neck cancer in the Republic of Ireland British Journal of Cancer ·B. Herity, M. Moriarty, G J Bourke, L Daly	1981	46
9	Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity British Journal of Cancer ·Colin Seymour, Carmel Mothersill, R Mooney, M. Moriarty, Keith F. Tipton	2003	44
10	Lymphoid irradiation in intractable rheumatoid arthritis. A double‐blind, randomized study comparing 750‐rad treatment with 2,000‐rad treatment Arthritis & Rheumatism ·John G. Hanly, Jaythoon Hassan, M. Moriarty, Ciaran Barry, J Molony, Eoin Casey, Alex Whelan, Conleth Feighery, Barry Bresnihan	1986	30
11	Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer Molecular BioSystems ·Paul Dowling, Damian Pollard, Annemarie Larkin, Michael Henry, Paula Meleady, Kathy Gately, Kenneth J. O’Byrne, Martin P. Barr, Vincent J. Lynch, Jo Ballot, John Crown, M. Moriarty, E O’Brien, Ross Morgan, Martin Clynes	2014	26
12	The role of tobacco and alcohol in the aetiology of lung and larynx cancer British Journal of Cancer ·B. Herity, M. Moriarty, L Daly, Jeffrey Dunn, G J Bourke	1982	26
13	(ICORG 05-03): prospective randomized non-inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysis Acta Oncologica ·K. A. Lee, Mary Dunne, Cormac Small, Paul Kelly, Orla McArdle, Joe M. O’Sullivan, Dayle Hacking, M. Pomeroy, John Armstrong, M. Moriarty, A. Clayton-Lea, Imelda Parker, Conor D. Collins, P. Thirion	2018	25
14	A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer British Journal of Cancer ·DERMOT A. O'SULLIVAN, Paul Dowling, Helena Joyce, Edel McAuley, Andrew McCann, Michael Henry, Brianán McGovern, Paul Barham, Fergal C. Kelleher, Jean Murphy, Susan Kennedy, Niall Swan, M. Moriarty, Martin Clynes, Annemarie Larkin	2017	21
15	Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression British Journal of Cancer ·P. Thirion, Mary Dunne, Paul Kelly, Aileen Flavin, Joe M. O’Sullivan, Dayle Hacking, W. Sąsiadek, Cormac Small, M. Pomeroy, Joseph D. Martin, Orla McArdle, Imelda Parker, Lydia O’Sullivan, Aoife M. Shannon, A. Clayton-Lea, Conor D. Collins, Michael R. Stevenson, Alberto Alvarez‐Iglesias, John G. Armstrong, M. Moriarty	2020	21
16	A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts Proteomes ·Orla Coleman, Michael Henry, Fiona O’Neill, Sandra Roche, Niall Swan, Lorraine Boyle, Jean Murphy, Justine Meiller, Neil T. Conlon, Justin Geoghegan, Kevin C. Conlon, Vincent J. Lynch, Ninfa L. Straubinger, Robert M. Straubinger, G. McVey, M. Moriarty, Paula Meleady, Martin Clynes	2018	21
17	ICORG 05-03: Prospective Randomized Non-Inferiority Phase 3 Trial Comparing Two Radiation Schedules in Malignant Spinal Cord Compression not Proceeding with Surgical Decompression International Journal of Radiation OncologyBiologyPhysics ·P. Thirion, Lydia O’Sullivan, A. Clayton-Lea, Cormac Small, Orla McArdle, Paul Kelly, Imelda Parker, John O’Sullivan, Dayle Hacking, Conor D. Collins, M. Pomeroy, M. Moriarty	2014	21
18	Taurine attenuates radiation-induced lung fibrosis in C57/Bl6 fibrosis prone mice Irish Journal of Medical Science (1971 -) ·W. B. Robb, Claire Condron, M. Moriarty, T. N. Walsh, D. J. Bouchier‐Hayes	2009	18
19	Metabolomic and proteomic analysis of breast cancer patient samples suggests that glutamate and 12-HETE in combination with CA15-3 may be useful biomarkers reflecting tumour burden Metabolomics ·Paul Dowling, Michael Henry, Paula Meleady, Colin Clarke, Kathy Gately, Kenneth J. O’Byrne, Elizabeth Connolly, Vincent J. Lynch, Jo Ballot, Giuseppe Gullo, John Crown, M. Moriarty, Martin Clynes	2014	16
20	Lymphoid irradiation in intractable rheumatoid arthritis. Long‐term followup of patients treated with 750 rads or 2,000 rads Arthritis & Rheumatism ·Muriel Soden, Jaythoon Hassan, David L. Scott, John G. Hanly, M. Moriarty, Alex Whelan, Conleth Feighery, Barry Bresnihan	1989	15

About M. Moriarty

M. Moriarty is a scholar working on Oncology, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 60 papers that have together received 1.8k indexed citations. Recurring topics across this work include Management of metastatic bone disease (7 papers), Effects of Radiation Exposure (6 papers), Spine and Intervertebral Disc Pathology (6 papers), Advanced Radiotherapy Techniques (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (4 papers), Radiation Therapy and Dosimetry (4 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). The work is most often cited by research in Oncology (815 citations), Cancer Research (232 citations), Pulmonary and Respiratory Medicine (467 citations), Surgery (552 citations) and Otorhinolaryngology (47 citations). M. Moriarty has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include David Gibbons, John Hyland, D. Fennelly, Anne White, Diarmuid P. O’Donoghue, Darren Treanor, Kieran Sheahan, Hugh Mulcahy, Ronan Ryan and Martin Clynes. Their work appears in journals such as British Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics, British Journal of Radiology, Radiotherapy and Oncology and Histopathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact